Block Pain Receptors with Proleviate - An Overview
The activation of CB1 and CB2 inhibits the development of intracellular cAMP, as a result leading to an amazing reduction on the excitatory outcome within the neurons [88,89]. Furthermore, the activation of CB2 can even more prevent the mast cell degranulation and the discharge of pro-inflammatory mediators, creating the reduction in pain sensation